Crunching the numbers for SXT... Refresh in a moment for the full analysis.
SENSIENT TECHNOLOGIES CORP (SXT)
Healthcare
weak
$93.16
Updated: 2026-04-12
42
TradeApes Score
reduce
Financial Strength
40
Weak
Operating Trend
20
Stressed
Valuation
50
Mixed
Capital Allocation
45
Mixed
Risk
80
Strong
Key Findings
+
Adequate interest coverage — EBIT covers interest 4–10×
−
Sharp revenue decline — sales down more than 15% year over year
See the full analysis
Quarterly financials, DCF valuation model, Watchlist, and Stock Screener.
Create Free Account
Scores and valuations are model outputs, not investment advice. TradeApes does not provide financial, tax, or investment advice.